Astria Therapeutics (ATXS) Insider Trading & Ownership $6.81 -0.01 (-0.15%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$6.81 0.00 (0.00%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Astria Therapeutics (NASDAQ:ATXS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.90%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$51.58 MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$111,396.00 Get ATXS Insider Trade Alerts Want to know when executives and insiders are buying or selling Astria Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ATXS Insider Buying and Selling by Quarter Astria Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/1/2024Perceptive Advisors LlcDirectorBuy2,481,350$12.09$29,999,521.50 1/29/2024Christopher MorabitoinsiderSell9,200$11.15$102,580.00 1/26/2024Christopher MorabitoinsiderSell800$11.02$8,816.00 12/21/2023Perceptive Advisors LlcDirectorBuy740,000$6.20$4,588,000.00 10/16/2023Perceptive Advisors LlcDirectorBuy1,074,608$6.51$6,995,698.08 12/19/2022Perceptive Advisors LlcDirectorBuy908,265$11.01$9,999,997.65 (Data available from 1/1/2013 forward) ATXS Insider Trading Activity - Frequently Asked Questions Who is on Astria Therapeutics's Insider Roster? The list of insiders at Astria Therapeutics includes Christopher Morabito, and Perceptive Advisors Llc. Learn more on insiders at ATXS. What percentage of Astria Therapeutics stock is owned by insiders? 2.90% of Astria Therapeutics stock is owned by insiders. Learn more on ATXS's insider holdings. Which Astria Therapeutics insiders have been buying company stock? The following insider purchased ATXS shares in the last 24 months: Perceptive Advisors Llc ($41,583,219.58). How much insider buying is happening at Astria Therapeutics? Insiders have purchased a total of 4,295,958 ATXS shares in the last 24 months for a total of $41,583,219.58 bought. Which Astria Therapeutics insiders have been selling company stock? The following insider sold ATXS shares in the last 24 months: Christopher Morabito ($111,396.00). How much insider selling is happening at Astria Therapeutics? Insiders have sold a total of 10,000 Astria Therapeutics shares in the last 24 months for a total of $111,396.00 sold. Astria Therapeutics Key ExecutivesMs. Jill C. Milne Ph.D. (Age 56)Co-Founder, CEO, President & Director Compensation: $938.78kMr. John RueschSenior Vice President of Pharmaceutical Sciences & Technical Operations More Insider Trading Tools from MarketBeat Related Companies Arcutis Biotherapeutics Insider Buying Amphastar Pharmaceuticals Insider Buying Immunocore Insider Buying Kiniksa Pharmaceuticals Insider Buying Dyne Therapeutics Insider Buying Structure Therapeutics Insider Buying Ardelyx Insider Buying Nurix Therapeutics Insider Buying Vir Biotechnology Insider Buying Syndax Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:ATXS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astria Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astria Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATXS Stock Alerts